Dermatology at Mass General Brigham is complex, collaborative, and cutting-edge. From safe, effective treatments for severe acne to novel therapeutics for rare skin diseases, discoveries emerging from the Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) are leading the field in innovation.
The Dermatology departments drive investment in Partners-derived therapies, devices, and procedures to expedite the pathway from discovery to commercial development. This Market Sector encompasses research and clinical capabilities at the BWH and MGH that cover the entire spectrum of dermatology, including autoimmune disorders, melanoma and other cancers, plastic surgery, burn care, and treatment for both common and rare conditions of the skin, nails and hair.
In this space the Wellman Center for Photomedicine remains a leaders in the field. During the last 10 years, Wellman’s products have produced more than $7 Billion in sales.